ANI Pharma (NASDAQ: ANIP) reported Q3 EPS of ($0.37), versus $0.04 reported last year. Revenue for the quarter came in at $52.1 million, versus $52.98 million reported last year.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.